Literature DB >> 21475130

Autoimmune lymphoproliferative syndrome: new approaches to diagnosis and management.

David T Teachey1.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21475130

Source DB:  PubMed          Journal:  Clin Adv Hematol Oncol        ISSN： 1543-0790


× No keyword cloud information.
  6 in total

Review 1.  New advances in the diagnosis and treatment of autoimmune lymphoproliferative syndrome.

Authors:  David T Teachey
Journal:  Curr Opin Pediatr       Date:  2012-02       Impact factor: 2.856

Review 2.  Diagnosis and management of autoimmune cytopenias in childhood.

Authors:  David T Teachey; Michele P Lambert
Journal:  Pediatr Clin North Am       Date:  2013-10-05       Impact factor: 3.278

3.  Sirolimus is effective in relapsed/refractory autoimmune cytopenias: results of a prospective multi-institutional trial.

Authors:  Karen L Bride; Tiffaney Vincent; Kim Smith-Whitley; Michele P Lambert; Jack J Bleesing; Alix E Seif; Catherine S Manno; James Casper; Stephan A Grupp; David T Teachey
Journal:  Blood       Date:  2015-10-26       Impact factor: 22.113

Review 4.  Autoimmune lymphoproliferative syndrome: more than a FAScinating disease.

Authors:  Karen Bride; David Teachey
Journal:  F1000Res       Date:  2017-11-01

5.  Sirolimus is effective in autoimmune lymphoproliferative syndrome-type III: A pedigree case report with homozygous variation PRKCD.

Authors:  Hao Gu; Zhenping Chen; Jie Ma; Jing Wang; Rui Zhang; Runhui Wu; Tianyou Wang
Journal:  Int J Immunopathol Pharmacol       Date:  2021 Jan-Dec       Impact factor: 3.219

Review 6.  Targeting the PI3K/AKT/mTOR signaling axis in children with hematologic malignancies.

Authors:  David Barrett; Valerie I Brown; Stephan A Grupp; David T Teachey
Journal:  Paediatr Drugs       Date:  2012-10-01       Impact factor: 3.930
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.